je.st
news
Tag: pfizers
FDA clears expanded use of Pfizer's breast cancer med IBRANCE
2016-02-20 09:04:41| Biotech - Topix.net
The FDA approves Pfizer's supplement New Drug Application for IBRANCE . It is now cleared for the treatment of hormone receptor-positive , human epidermal growth factor receptor 2-negative advanced/metastatic breast cancer in combination with fulvestrant [AstraZeneca's FASLODEX ] in women with disease progression following endocrine therapy.
Tags: med
expanded
cancer
breast
The racket behind Pfizer's new $9,850 breast cancer drug
2015-12-12 11:33:08| Biotech - Topix.net
Laura Robison of Minneapolis used crowdfunding to help pay for Ibance, a breast cancer treatment drug that hit the market less than a year ago. Robison's disease is Stage 3. She's seeking donations to cover her medical expenses, which add up fast considering the monthly cost for Ibance is almost $10,000.
Tags: drug
cancer
breast
racket
Donald Trump slammed Pfizer's 'disgusting' megamerger
2015-11-28 18:05:34| Biotech - Topix.net
Real-estate mogul Donald Trump isn't happy with Pfizer and Allergan's announcement on Monday that the two companies would merge to form a corporate drug-making behemoth. "The fact that Pfizer is leaving our country with a tremendous loss of jobs is disgusting," he said in a statement to Business Insider.
Tags: donald
trump
slammed
donald trump
Premarket Biotech Digest: Clovis A Buy, Cellceutix Rallies, Pfizer's Avelumab Milestone
2015-11-27 17:06:01| Biotech - Topix.net
Click this link to find out how much you can save). . Clovis Oncology suffered a major setback earlier this month.
Tags: buy
digest
biotech
milestone
India rejects patent on Pfizer's arthritis drug
2015-09-07 11:48:19| Biotech - Topix.net
India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country. Pfizer sought a patent that covers an important chemical formulation of the active compound in the medicine, but the Indian Patent Office said the company would have to establish that the compound for which it is seeking a patent is therapeutically more effective than the active compound.
Tags: india
drug
patent
arthritis